The energy sector is deeply out of favor, as oil and natural gas companies pull back in the face of depressed oil prices. But the different parts of the industry aren't impacted equally. Midstream players like Canada's Enbridge (NYSE: ENB) and U.S.-domiciled Enterprise Products
Moderna (NASDAQ: MRNA) hasn't even been publicly traded for two years, but shares have risen by leaps and bounds since the company held its initial public offering (IPO) on Dec. 7, 2018, when the stock was priced at just $23. Today, you can purchase one share of Moderna for roug
There have been more than 20 million coronavirus cases and 749,000 COVID-19-related deaths worldwide. The U.S. alone has recorded 5 million cases and 169,000 related deaths. Before life, and the economy, can return to normal, a safe and effective vaccine must be made widely avai
Tens of millions of Americans have lost their jobs in the course of the COVID-19 outbreak, so much so that the U.S. unemployment rate has been in double digit territory since April. But not everyone on unemployment has completely lost a job. Some employees are currently furlough
With the breakout of the COVID-19 pandemic earlier this year, the cruise industry is facing a historically tough challenge. As numerous countries imposed lockdowns and closed borders, cruise companies joined airlines in grounding their fleets as cancellations mounted with alarmi
This year has not been a good one for income investors. With the COVID-19 outbreak shutting down much of the global economy, many companies slashed their payouts to preserve cash. While investors experienced industrywide dividend destruction, the energy sector was among the har
Friday's upbeat retail data comes at a critical time since the market will get earnings reports from some notable retailers, including Walmart (WMT), Target (TGT) and and Home Depot (HD).
The stock market experienced one of its steepest declines less than five months ago. Many stocks have since recovered and are putting up impressive gains, but there's no guarantee that this recent rally will continue. The U.S. unemployment rate is still above 10%, state and loca
The stock market had a great run in the 2010s, but 2020 has already reminded us that crashes do happen -- and that they're pretty unpleasant. A sudden 30% drop in the value of your long-term savings can reverse years of contributions and investment growth, putting your retiremen
Gilead Sciences (NASDAQ: GILD) has been at the forefront of the coronavirus treatment space since the early days of the pandemic. During this past spring and early summer, the company donated almost a million doses of its antiviral medication, remdesivir, to the U.S. government
Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the bigger names in the cannabis industry. They're both facing similar challenges -- namely, how to keep growing amid rising competition while also getting closer to breakeven. Within the past 14 months, bot
Inovio Pharmaceuticals (NASDAQ: INO) has enjoyed a remarkable year so far by any standard. The biotech is in the thick of the race to develop a COVID-19 vaccine. It has made significant progress with its other pipeline candidates. Inovio's shares have skyrocketed close to 350%.
Which of Pfizer's (NYSE: PFE) products grab investors' attention the most? I'd put BNT162b2, the COVID-19 vaccine candidate that Pfizer is developing with BioNTech, high on the list. The company's top-selling drugs Ibrance and Eliquis would also certainly make the cut. Pneumoco
Former Indian Prime Minister Indira Gandhi once said, "Popularity is not a guarantee of quality." She was exactly right. And her statement is applicable to investing as much as it is anything else.
If you're retired (or close to that point), there are typically two main things you'll look for in stocks. First, the stock should pay an attractive dividend. Second, the underlying business should be solid and reliable.
Being an investor in 2020 hasn't been easy. The uncertainty and panic created by the coronavirus disease 2019 (COVID-19) pandemic initially sent equities to their steepest bear-market tailspin in history. This was followed by one of the strongest quarterly rallies in a decade. E
Machine vision company Cognex Corporation (NASDAQ: CGNX) has had a difficult year, but somehow the stock is up nearly 17% at the time of writing. What's going on, and has the rally in the share price got ahead of itself in the last few months? Let's take a closer look.
The COVID-19 pandemic has challenged many smaller companies. Investors who favor stocks below $2 billion in market capitalization for growth potential are probably wondering if it's safe to put new money there with so many uncertainties about how the pandemic is going to play ou
Before the COVID-19 crisis, many people worked remotely by choice. Now, countless workers are performing their jobs from home or other off-site locations involuntarily -- whether because it's unsafe to go into an office, there are few child care options, or both. Some workers ar